Mechanism of lymphocyte activation: the binding of phytohemagglutinin to the lymphocyte surface. 1977

B Perlés, and M T Flanagan, and J Auger, and M J Crumpton

The dynamics of phytohemagglutinin (PHA)-lymphocyte interaction was studied using 125I-labeled PHA (leucoagglutinin) and pig mesenteric lymph node lymphocytes that had been depleted of erythrocytes, dead cells, adherent cells and immunoglobulin-bearing cells. Evidence was obtained that PHA stimulated the majority of the lymphocytes to transform. Binding of PHA at 37 degrees C was fairly rapid (rate constant for association: 2.6 X 10(5) M-1 sec-1), saturable, reversible and specifically inhibited by N-acetylgalactosamine (Kdiss: 3 X 10(-4) M) and unlabeled PHA. A Scatchard plot was curvilinear and gave evidence for 3.6 X 10(5) binding sites per cell comprising 8.7% of high affinity sites (Kdiss: 3.7 X 10(-9) M) and 91.3% of lower affinity (Kdiss: 1.4 X 10(-7) M). About 20% of the sites were occupied under culture conditions giving maximal transformation. Alternative explanations for the curvilinear plot included negative cooperative interactions and/or increase in affinity through multivalent interaction. Negative cooperativity was supported by the demonstration that free PHA promoted the dissociation of bound PHA. Binding was not affected by metabolic inhibitors, and binding to purified lymphocyte plasma membrane resembled that to whole cells. These results suggested that PHA binding to whole lymphocytes was not grossly influenced by "capping", endocytosis and shedding.

UI MeSH Term Description Entries
D007152 Immunologic Capping An energy dependent process following the crosslinking of B CELL ANTIGEN RECEPTORS by multivalent ligands (bivalent anti-antibodies, LECTINS or ANTIGENS), on the B-cell surface. The crosslinked ligand-antigen receptor complexes collect in patches which flow to and aggregate at one pole of the cell to form a large mass - the cap. The caps may then be endocytosed or shed into the environment. Capping, Immunologic,Immunological Capping,Capping, Immunological
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D000116 Acetylgalactosamine The N-acetyl derivative of galactosamine. 2-Acetamido-2-D-galactopyranose,2-Acetamido-2-Deoxy-D-Galactose,2-Acetamido-2-Deoxygalactose,N-Acetyl-D-Galactosamine,2 Acetamido 2 D galactopyranose,2 Acetamido 2 Deoxy D Galactose,2 Acetamido 2 Deoxygalactose,N Acetyl D Galactosamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
March 1977, The Journal of biological chemistry,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
March 1970, Journal of the Reticuloendothelial Society,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
January 1970, International archives of allergy and applied immunology,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
May 1969, Biochimica et biophysica acta,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
January 1982, Progress in clinical and biological research,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
March 1989, Biochemistry international,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
November 1979, Immunology,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
July 1969, Saishin igaku. Modern medicine,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
April 1973, Experimental cell research,
B Perlés, and M T Flanagan, and J Auger, and M J Crumpton
January 1973, Cellular immunology,
Copied contents to your clipboard!